A pilot study of galunisertib (LY2157299) plus stereotactic body radiotherapy (SBRT) in advanced hepatocellular carcinoma (HCC).

被引：0
|
作者：
Reiss, Kim Anna
Ben-Josef, Edgar
Damjanov, Nevena
Hoteit, Maarouf
O'Hara, Mark H.
Karasic, Thomas Benjamin
Teitelbaum, Ursina R.
Schneider, Charles
O'Dwyer, Peter J.
Carpenter, Erica L.
Mick, Rosemarie
Vonderheide, Robert H.
机构：
[1] Univ Penn, Philadelphia, PA USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
[3] Helen F Graham Canc Ctr, Christiana Care Hlth Syst, Newark, DE USA
[4] Univ Penn, Sch Med, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.TPS528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS528
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Randomized dose comparison phase II study of the oral transforming growth factor-beta (TGF-β) receptor I kinase inhibitor LY2157299 monohydrate (LY) in patients with advanced hepatocellular carcinoma (HCC)
    Faivre, Sandrine J.
    Santoro, Armando
    Kelley, Robin Katie
    Merle, Philippe
    Gane, Ed
    Douillard, Jean-Yves
    Waldschmidt, Dirk
    Mulcahy, Mary Frances
    Costentin, Charlotte
    Minguez, Beatriz
    Papappicco, Pasqua
    Gueorguieva, Ivelina
    Cleverly, Ann
    Desaiah, Durisala
    Lahn, Michael M. F.
    Murray, Nicola
    Benhadji, Karim A.
    Raymond, Eric
    Giannelli, Gianluigi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Methodological concerns for investigating the effects of mid-treatment break of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC)
    Kibe, Yuichi
    Takeda, Atsuya
    RADIOTHERAPY AND ONCOLOGY, 2020, 147 : 234 - 234
  • [23] Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-alone in Unresectable Hepatocellular Carcinoma (HCC)
    Chiang, Chi Leung
    Lee, Francis Ann Shing
    Chan, Kenneth Sik Kwan
    Lee, Venus Wan Yan
    Chiu, Keith Wan Hang
    Ho, Ryan Lok Man
    Fong, John Ka Shun
    Wong, Natalie Sean Man
    Yip, Winnie Wing Ling
    Yeung, Cynthia Sin Yu
    Lau, Vince Wing Hang
    Man, Kwan
    Kong, Feng-Ming
    Chan, Albert Chi Yan
    LIVER CANCER, 2024, 13 (03) : 273 - 284
  • [24] Stereotactic body radiotherapy (SBRT) for inoperable hepatocellular carcinoma: A retrospective analysis.
    Hanumanthappa, Nikesh
    Manoor, Vikram Maiya
    Premitha, R.
    Naik, Radheshyam
    Anchineyan, Pichandi
    Swamy, Kumara
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] Plasma microRNAs associated with overall survival in patients with hepatocellular carcinoma treated with galunisertib (LY2157299 monohydrate), an inhibitor of transforming growth factor-β receptor1
    Estrem, Shawn T.
    Man, Michael
    Zhang, Xuekui
    Nguyen, Duytrac
    Yu, Danni
    Lahn, Michael M.
    Cleverly, Ann
    Desaiah, Durisala
    Faivre, Sandrine
    Gianneli, Gianluigi
    Benhadji, Karim A.
    CANCER RESEARCH, 2016, 76
  • [26] Stereotactic Body Radiotherapy vs Transarterial Chemoembolization In Locally Advanced Hepatocellular Carcinoma (HERACLES: Hepatocellular Carcinoma Stereotactic Radiotherapy Clinical Efficacy Study)
    Brunner, T. B.
    Bettinger, D.
    Schultheiss, M.
    Maruschke, L.
    Bartl, N.
    Kirste, S.
    Bamberg, F.
    Thimme, R.
    Grosu, A.
    Gkika, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E574 - E574
  • [27] Stereotactic Body Radiotherapy vs Transarterial Chemoembolisation in Locally Advanced Hepatocellular Carcinoma (Heracles: Hepatocellular Carcinoma Stereotactic Radiotherapy Clinical Efficacy Study)
    Gkika, Eleni
    Bettinger, Dominik
    Schultheiss, Michael
    Maruschke, Lars
    Bartl, Nico
    Kirste, Simon
    Bamberg, Fabian
    Ihorst, Gabriele
    Thimme, Robert
    Grosu, Anca-Ligia
    Brunner, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 165 - 165
  • [28] EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECEPTOR I KINASE INHIBITOR, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: PHASE 2 STUDY RESULTS OF SAFETY, EFFICACY AND PK/PD
    Giannelli, G.
    Faivre, S.
    Santoro, A.
    Kelley, R. K.
    Merle, P.
    Gane, E.
    Douillard, J. -Y.
    Waldschmidt, D.
    Mulcahy, M.
    Costentin, C.
    Minguez, B.
    Papappicco, P. P.
    Gueorguieva, I.
    Cleverly, A.
    Desaiah, D.
    Lahn, M. M.
    Ameryckx, S.
    Benhadji, K. A.
    Raymond, E.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S52 - S53
  • [29] Combined Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) vs. TACE in Locally Advanced Hepatocellular Carcinoma (HCC): Propensity Score Matching Analysis
    Chiang, C. L.
    Chan, A. C. Y.
    Chiu, W. H. K.
    Kong, F. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E35 - E36
  • [30] Pilot study of stereotactic body radiotherapy for huge hepatocellular carcinoma unsuitable for other therapies
    Shin, Young-Joo
    Kim, Mi-Sook
    Yoo, Seong Yul
    Cho, Chul Koo
    Seo, Young Seok
    Kang, Jin-kyu
    Park, Su Cheol
    Han, Chul Ju
    Kim, Sang Beom
    Lee, Byong Hee
    Lee, Dong Han
    TUMORI JOURNAL, 2010, 96 (01): : 65 - 70
12345